On 13th May 2016 in Bonerowski ***** Palace Hotel in Cracow will take place annual General Meeting of the International Law Life Science Organisation BioLAw Europe FmbA (“BLE”). The General Meeting is the most important event considering making decisions and summarising its yearly activity. In order to emphasise the international character of this community, the General Meeting of BLE takes place every year in a different city chosen from the member states constituting the Organisation.
Fast development of health sector in Poland provides the opportunities to use the results of medical research. The most significant effect can be visible on the example of clinical trials, which are being increasingly more often conducted in Poland (over 40 thousands of patients in Poland take part in clinical trials almost every year). The clinical trials verify the effectiveness and the safety of new medicinal products, taking into account, among others, ethic rules resulting from Good Clinical Practice, WMA Declaration of Helsinki, Regulation (EU) No 536/2014, Polish Pharmaceutical Law or Polish Medical Profession Act. The text focuses on legal regulations applicable to the Polish market of clinical trials and discusses the advantages that the Polish market offers for clinical trials, also involving foreign investors.
The information was prepared by Anna Bednarska of KG Legal Polish Law Firm. KG Legal provides specialised legal assistance to IT, Life Science as well as investment processes in Poland and organises networking between Polish and international companies and research centres.
The article was prepared by KG LEGAL KIEŁTYKA GŁADKOWSKI based in Cracow, Poland, specialising in cross border cases, with its focus on new technologies, IT and life science, discusses start-ups, differences between business secret and know-how and the value of these for a company being a start-up, protection of intellectual property, the importance of patent law for start-ups, protection of biotechnological inventions, copyright, the patentability of inventions, protection of IT solutions, procedures for obtaining a patent and rights granted under a patent.
The information was prepared by Kamil Trzaskoś of KG Legal Polish Law Firm. KG Legal provides specialised legal assistance to IT, Life Science as well as investment processes in Poland and organises networking between Polish and international companies and research centres.
The association BioLaw Europe FmbA is a new initiative of the European law firms with extensive recognition in life science specialisation.
The strength of this organization is the fact that is comprises the law firms from the European Union and EFTA having thorough expertise in life science area. The founders of the organization are three law firms from Denmark, the UK and Spain.
BioLaw Europe aims to create a platform for professional marketing, collaboration, education, training and communication for the entities related to broadly understood life science sector.
The association will attempt to encourage the entities operating in different jurisdictions in the field of life science to cooperate and work on mutual projects.
Due to the fact that Atty. Jakub Gładkowski has been appointed the auditor of the Management Board of BioLaw Europe for 2015, KG Legal has created a new thematic portal BIOLAW EUROPE Life Science, which is a response to the current information needs of the organization and the place for publications on the issues related to life science sector.
KG Legal Law Firm has obtained the membership of the British Institute of Export which is the professional membership body representing and supporting the interests of everyone involved in importing, exporting and international trade. The Institute is the leading authority in best practice and competence for businesses trading globally.
The membership in IOE will help KG Legal to provide professional support to the expansion of foreign business entities in the Polish jurisdiction.
The article was prepared by KG LEGAL KIEŁTYKA GŁADKOWSKI based in Cracow, Poland, specialising in cross border cases, with its focus on new technologies, IT and life science, discusses start-ups, differences between business secret and know-how and the value of these for a company being a start-up, protection of intellectual property, the importance of patent law for start-ups, protection of biotechnological inventions, copyright, the patentability of inventions, protection of IT solutions, procedures for obtaining a patent and rights granted under a patent.
